NewcelX Ltd.(NCEL)

Biotechnology · Kloten, ZH

$2.96+0.10 (+3.52%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:47:31.928Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:47:31.928Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.9607
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: ceb9d7bb150905ac81611c4688aa1bd793b2f4eb464ba4dc05e218b0340a6d90

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

NCEL PE Ratio Metrics

PE RATIO

N/A

NCEL Competitors' PE Ratio

NCEL

NewcelX Ltd.

Current

Market Cap

$1.33M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTL

Artelo Biosciences, Inc.

vs NCEL

Market Cap

$1.34M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNPX

Genprex, Inc.

vs NCEL

Market Cap

$1.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JUNS

Jupiter Neurosciences, Inc.

vs NCEL

Market Cap

$1.39M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IVF

INVO Fertility, Inc.

vs NCEL

Market Cap

$1.42M

PE Ratio

N/A

TTM Avg

21295.08

3Y Avg

21295.08

5Y Avg

21295.08

CRIS

Curis, Inc.

vs NCEL

Market Cap

$1.46M

PE Ratio

N/A

TTM Avg

47.01

3Y Avg

47.01

5Y Avg

34.74

NXGL

NEXGEL, Inc.

vs NCEL

Market Cap

$1.47M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELAB

PMGC Holdings Inc.

vs NCEL

Market Cap

$1.49M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMCC

IM Cannabis Corp.

vs NCEL

Market Cap

$1.17M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs NCEL

Market Cap

$1.52M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
NewcelX Ltd. (NCEL)	$1.33M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.34M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.32M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.39M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.42M	N/A	21295.08	21295.08	21295.08
Curis, Inc. (CRIS)vs ›	$1.46M	N/A	47.01	47.01	34.74
NEXGEL, Inc. (NXGL)vs ›	$1.47M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A	N/A	N/A	N/A
IM Cannabis Corp. (IMCC)vs ›	$1.17M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.52M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.96

Forward EPS (Est.)

$-1.18

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

NCEL PE Ratio Metrics

NCEL Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics